baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

A2A SpA/ IT0001233417 /

10/11/2024 5:35:15 PM	Chg. +0.06	Volume	Bid5:35:15 PM	Ask5:35:15 PM	Market Capitalization	Dividend Y.	P/E Ratio
2.08EUR	+2.99%	3.58 mill. Turnover: 3.14 mill.	-Bid Size: -	-Ask Size: -	6.53 bill.EUR	4.60%	9.92

GlobeNewswire 8/8 iTeos Reports Second Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire 8/6 Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2024 Financial Results

GlobeNewswire 7/30 180 Life Sciences Announces Positive Topline Results of a Clinical Pharmacology Study Testing a New ...

GlobeNewswire 5/10 iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates

GlobeNewswire 5/6 Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2024 Financial Results

GlobeNewswire 3/19 Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financ...

Newsfile Corp 3/8 Noda Presents Report on Key Payment Trends: Diverse PaymentMethods, AI, and More

GlobeNewswire 3/6 iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates

GlobeNewswire 1/8 iTeos Announces 2024 Strategic Priorities and Anticipated Milestones

GlobeNewswire 11/28/2023 Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update

GlobeNewswire 11/7/2023 Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2023 Financial Results

GlobeNewswire 11/7/2023 iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates

GlobeNewswire 11/6/2023 Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy...

Newsfile Corp 10/4/2023 Noda and Tickets Travel Network Forge Partnership for Seamless Travel Payments

GlobeNewswire 9/21/2023 Bluejay Therapeutics expands management team and hired Christopher Holterhoff as senior Vice Preside...

GlobeNewswire 9/20/2023 Innovative Payment Solutions Announces Funding of Second $500,000 Capital Contribution to IPSIPay Ex...

GlobeNewswire 9/5/2023 Portage Biotech Announces Collaboration with Merck to Evaluate Two Next-Generation Adenosine Antagon...

GlobeNewswire 8/30/2023 Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023 and Business Update

GlobeNewswire 3/10/2022 Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financ...

GlobeNewswire 3/3/2022 Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2021 Finan...

GlobeNewswire 2/10/2022 Sosei Heptares Operational Highlights and Consolidated Results for 12 Months ended 31 December 2021

GlobeNewswire 2/2/2022 Bluejay Therapeutics Announces the Appointment of Nancy Shulman, M.D., as Chief Medical Officer

GlobeNewswire 1/14/2022 Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Initiated Phase 1/1b Clinical Trial o...

GlobeNewswire 1/3/2022 iTeos to Present at the 40th Annual J.P. Morgan Healthcare Conference

GlobeNewswire 12/9/2021 iTeos Announces New Data for its Anti-TIGIT Antibody, EOS-448, at the American Society of Hematology...

A2A SpA/ IT0001233417 /

If you wish to receive reply to your feedback, please provide your email address.